(+)-VINCRISTINE
Ovarian Sex Cord Tumor With Annular Tubules
ARCAGY/ GINECO GROUPSmall moleculePhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Ovarian Sex Cord Tumor With Annular Tubules cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Irinotecan ARCAGY/ GINECO GROUP | Phase 2 | BB |
CIS-DIAMMINEDICHLOROPLATINUM II GOG Foundation | Phase 2 | CCC |
Carboplatin GOG Foundation | Phase 2 | CCC |
ETOPOSIDE GOG Foundation | Phase 2 | CCC |
BLEOMYCIN GOG Foundation | Phase 2 | CCC |
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →